Transcutaneous Electrical Nerve Stimulation for Chronic Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Loma Linda University Health, Loma Linda, CA
Chronic Pain
Transcutaneous Electrical Nerve Stimulation - Device
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This will be a prospective randomized controlled trial with sixty adults, 20 to 40 years of age. There will be three groups as follows: the normal group, control group, and intervention group where subjects will receive instructions for home use of TENS for pain reduction. The aim is for an equal distribution of males and females in each group.

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Change between baseline assessment and Day Eight post-enrollment

Change between Day eight post-enrollment and Day Thirty post-enrollment
Neck disability
Change between baseline assessment and Day Eight post-enrollment
Decrease in chronic subclinical neck or upper quadrant pain
Level of anxiety
Neck proprioception

Trial Safety

Trial Design

3 Treatment Groups

Subjects without Pain
1 of 3
Subjects with Pain and No Intervention
1 of 3
Subjects with Pain and Intervention
1 of 3
Active Control
Experimental Treatment

60 Total Participants · 3 Treatment Groups

Primary Treatment: Transcutaneous Electrical Nerve Stimulation · No Placebo Group · N/A

Subjects with Pain and Intervention
Device
Experimental Group · 1 Intervention: Transcutaneous Electrical Nerve Stimulation · Intervention Types: Device
Subjects without Pain
Other
NoIntervention Group · 1 Intervention: No Intervention · Intervention Types: Other
Subjects with Pain and No Intervention
Other
NoIntervention Group · 1 Intervention: No Intervention · Intervention Types: Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcutaneous Electrical Nerve Stimulation
2013
N/A
~490

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change between baseline assessment and day eight post-enrollment
Closest Location: Loma Linda University Health · Loma Linda, CA
Photo of california 1Photo of california 2Photo of california 3
2010First Recorded Clinical Trial
2 TrialsResearching Chronic Pain
12 CompletedClinical Trials

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
281 Previous Clinical Trials
257,080 Total Patients Enrolled
2 Trials studying Chronic Pain
42 Patients Enrolled for Chronic Pain
Eric Johnson, DScPrincipal InvestigatorLoma Linda University Health

Eligibility Criteria

Age 18 - 65 · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.